Skip to main content
 

Hype or Hope? CIMAvax A Cuban Lung Cancer Vaccine

Friday, October 6, 2017

In the latest installment of our special series “Innovation Happens,” we take a look at CIMAvax, a promising lung cancer vaccine developed in Cuba that is getting a lot of attention here in the United States. It is being studied in an FDA approved clinical trial at Roswell Park Cancer Institute-- the first Cuban therapy to be tested in the US. Our guest is Dr. Mary Reid, the Director of Cancer Screening and Survivorship at Roswell Park and a key member of the team that is collaborating with Cuban scientists on CIMAvax. Dr. Reid shares with us the history of the vaccine and how it could spur a new age of American-Cuban medical collaboration.

The Importance of Clinical Trial Participation

Tuesday, January 10, 2017

Cancer clinical trials provide patients with access to new therapies. When a patient participates in a clinical trial they are helping to move cancer treatment forward and provide hope for the future of cancer care. However, less than 1/3 of all cancer clinical trials meet their recruitment goals, and only 2-3% of adults participate in a clinical trial. On this episode of Frankly Speaking About Cancer, host Kim Thiboldeaux is joined by two guests to discuss barriers to clinical trial enrollment and how we can overcome these barriers to create new cancer treatments.

Frankly Speaking About Cancer: Join host Kim Thiboldeaux, President and CEO of the Cancer Support Community, for a weekly radio broadcast empowering listeners to live well with cancer. Every Tuesday, 4PM ET (1PM PT)